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Abstract
Endoscopic third ventriculostomy (ETV) is an endoscopic fenestration between the floor 
of the third ventricle and subarachnoid space. It is the procedure of choice for obstructive 
hydrocephalus (HC). The indication includes obstructive HC caused by aqueduct steno-
sis, tumors, brain infarction, cystic lesions, hematoma, postinfectious and posthemorrhagic 
HC, malformation of the fourth ventricle, and further uncommon indications. In this chap-
ter, surgical techniques and the success rate of ETV in distinct indications will be presented 
and discussed. The overall success rate of ETV is reported at 60–90%. The outcome of the 
procedure depends highly on the underlying pathology and age. A very favorable outcome 
is reported in case of aqueduct stenosis (67–93.5%). High success rate is observed in case of 
cerebellar infarction (86%), tumors (56–81%), and intraventricular cysts (56–95%). In case of 
intraventricular hemorrhage (43–73%), infection (60–64%), anatomical aberration (21–80%), 
and communicating HC (65–72%), a significantly inferior success rate is reported. It is well 
known that ETV has a lower success rate in children (68–71%) compared to adults (70–
90%). The overall high clinical success rate in short-term and long-term follow-up confirms 
that ETV is the gold standard for treatment of occlusive HC. It is effective, safe, and simple.
Keywords: third ventriculostomy, hydrocephalus, neuroendoscopy, success rate, 
indication
1. Introduction
1.1. Classification of hydrocephalus
Walter Dandy classified hydrocephalus as “communicating” or “noncommunicating” type based 
on examinations with ventricle and lumbar puncture in 1913. He considered hydrocephalus as 
“noncommunicating” or “obstructive” if after the injection of a colored solution in the lateral 
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ventricle, the dye did not appear in the spinal fluid removed by lumbar puncture. In contrast, if 
this solution appeared, hydrocephalus was classified as “communicating” [1]. This classification 
was simple and useful to understand hydrocephalus, but first was found inadequate to under-
stand the pathophysiology [2]. The proposed classification is hydrocephalus without obstruction 
(true communicating hydrocephalus) in case of choroid plexus papilloma and with obstruction 
at the level of venous outflow (skull base anomalies and congenital heart disease), arachnoid 
granulations (hemorrhage and infection), basal cisterns (hemorrhage and infection), outlets of 
fourth ventricle (infection and Chiari malformation), Sylvian aqueduct (congenital anomalies 
and tumor compression), and foramen of Monro (congenital anomalies, tumor, and postshunt 
ventricular asymmetry) [2]. Nonetheless, the classic nomenclature remained in clinical practice 
due to its simplicity.
1.2. History of neuroendoscopy
The first neuroendoscopic procedure was introduced in 1910, when L’Espinasse performed 
a cauterization of plexus choroideus with a cystoscope. The other pioneer in neuroendos-
copy was Walter Dandy. He published his results in 1913. Clarifying the physiology, Dandy 
performed plexectomy to cease the cerebrospinal fluid (CSF) production as a treatment for 
communicating hydrocephalus. In case of obstruction, he created an internal bypass for com-
munication between the third ventricle and cortical subarachnoid space [2, 3].
The first endoscopic third ventriculostomy (ETV) was performed by William Mixter in 1923. 
This successful technique later served as a model for modern neuroendoscopy. He performed 
a perforation of the third ventricle floor by an intraventricular approach through the foramen 
of Monro. The invention of Hopkins optics, cold light sources, and digital cameras was a 
great development in the history of endoscopy. Following technical development and clinical 
application, neuroendoscopy spread over the world [3].
1.3. Endoscopic third ventriculostomy nowadays
For obstructive hydrocephalus, endoscopic third ventriculostomy is the procedure of choice. 
This is an endoscopic fenestration between the floor of third ventricle and subarachnoid 
space. The CSF flow can be restored and balanced out [4]. This procedure is considered effec-
tive, safe, and simple. The complication rate is lower as it has a lower infection rate; there is 
no foreign material and no overdrainage compared with shunt [4].
Nowadays, the use and role of endoscopic ventriculostomy expand continuously. It remains 
challenging to estimate and define the success of the procedure [5], even though many studies 
have overall focused on this topic [5–14].
2. Indications
In general, endoscopic third ventriculostomy is the gold-standard treatment for noncommu-
nicating hydrocephalus. The indication for ETV includes all cases with obstruction between 
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the third ventricle and the subarachnoid space with preserved CSF absorption from subarach-
noid space into the venous system [2, 14, 15]. In case of obstruction at the level of Pacchionian 
granulation and venous outflow, performing ETV is definitely not recommended [14].
2.1. Aqueduct stenosis
One of most common etiology of obstructive hydrocephalus is the aqueduct stenosis [16, 17] 
(Figures 1 and 2). The obstruction can be congenital or acquired. In 75% of cases, it is idio-
pathic. In remaining cases, it can be caused by infections, hemorrhages, or malformation of 
the central nervous system or can be related to genetic factors [16]. The first and best treatment 
option for this is ETV. Ventriculostomy has a good outcome regardless of etiology of the ste-
nosis, whether it is congenital, acquired, or tumor-related obstruction [14]. However, the suc-
cess rate is different in certain cases of the aqueduct stenosis. It depends on the etiology, age, 
clinical, and radiological characteristics [13]. In certain cases, as an alternative treatment or 
even simultaneous, aqueductoplasty may be performed [7, 18]. The result of aqueductoplasty 
is comparable with the success of ETV. As alternative treatment, it may be useful in case of 
thick and tough floor of the third ventricle preventing the hypothalamus or vessel injuries [18].
Figure 1. Aqueduct stenosis (MRI scan TRUFI sequence).
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2.2. Far distal obstruction
Obstruction distal to the fourth ventricle is a rare cause of hydrocephalus [19]. It can develop 
through intraventricular membranous obstruction [20, 21] or extraventricular compression 
[22] and in case of Dandy Walker syndrome [26] and Chiari malformation [23–25] (see below) 
[19]. Like all obstructive hydrocephalus, it may also be treated successfully with ventricu-
lostomy, although an additional surgical technique with flexible endoscope is required (see 
below).
2.3. Tumors and cystic lesions
Endoscopic third ventriculostomy might be a surgical option in case of tumor- or cyst-related 
hydrocephalus, where the CSF flow disturbance is distal from the place of ventriculostomy 
(Figures 3–5). Therefore, in selected cases, it might be performed in case of tumor localiza-
tion in the brainstem, posterior fossa, thalamus, pineal region, third and fourth ventricle, and 
other localization, e.g., cerebellopontine angle, frontal lobe, or diffuse growth pattern [27].
Figure 2. Aqueduct stenosis (left) MRI scan TRUFI sequence (right) endoscopic view.
Figure 3. Arachnoid cyst with compression of the CSF pathway (MRI scan TRUFI sequence). In this case, a cystostomy 
and simultaneous ETV were performed.
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In children, the posterior fossa is a common localization for various tumors (54–60% of brain 
tumors during childhood), and a hydrocephalus develops with high probability in these cases 
[13]. Frequent localizations are at the cerebellum, midline, brainstem, or cerebellopontine 
angle. Histologically the following tumors may occur: medulloblastoma, ependymoma, astro-
cytoma, ganglioglioma, cavernoma, primitive neuroectodermal tumor (PNET), meningioma, 
and others [28]. Gliomas in the midbrain and in the periaqueductal area are relatively rare and 
low grade. They show benign growth patterns, and malignant spreading is rare, although a 
suggested dissemination through CSF has already been reported [29]. The compression of the 
Figure 5. (a and b) Multiple cysts of the third ventricle with obstruction of the Sylvian aqueduct. ETV (see Figure 9) and 
cyst removal (c) were performed. (d) Free aqueduct.
Figure 4. Arachnoid cyst with compression of the CSF pathway (cisternography). Same patient as in Figure 3.
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fourth ventricle or the foramina of Magendie and Luschka leads to circulation disturbances 
and hydrocephalus [13]. ETV is recommended primarily for the treatment of children with 
midline posterior fossa tumor–related obstructions [30]. ETV can be combined with tumor 
biopsy, thus providing useful information for the diagnosis. In certain cases, even the tumor 
resection (e.g., third ventricle) might be performed [13, 30]. The resection alone can set the 
CSF pathway free, providing a normal CSF circulation. Therefore, performing ventriculos-
tomy routinely is not recommended. After tumor removal, not only the causal problem of 
hydrocephalus might be solved. With performing the ETV an intraperitoneal spreading of the 
chemotherapeutic drugs through the shunt can be avoided [32]. The time of ETV in relation to 
the tumor resection is still under discussion [13].
Beside posterior fossa tumors, the indication expands to pineal tumors and third ventricle 
tumors [33]. The pathology of these is various. The pathology includes, but is not limited to 
glial tumors, ependymoma, pinealoblastoma, pinealocytoma, meningioma, germ cell tumors, 
primitive neuroectodermal tumor, teratoma, epidermoid, metastasis, and cysts [34, 35]. 
Colloid cysts, arachnoid cysts with extension in the ventricles or midline, and quadrigeminal 
cysts can be treated with endoscopic cystectomy, cystocisternostomy, cystoventriculostomy, 
ventriculocystostomy, and ventriculocystocysternostomy [36]. Even a combination with ven-
triculostomy may be performed [13].
2.4. Cerebellar infarction
Cerebellar infarction with space-occupying effect might lead to obstruction of the CSF path-
way (Figure 6). The occurrence of stroke-related occlusive hydrocephalus is 10.9–27.2% of 
cerebellar stroke patients [37]. Deterioration of consciousness in case of cerebellar infarction 
can be caused by compression of the brainstem through increasing parenchymal edema or 
by hydrocephalus. A neurosurgical intervention is required in case of decline of conscious-
ness [7, 37, 38]. For treatment of hydrocephalus, the alternative options are external ventricle 
drainage (EVD), shunt placement, and ETV. However, not every hydrocephalus caused by cer-
ebellar infarction is a suitable candidate for ETV. In case of patients with severe deterioration 
of consciousness and/or brain stem compression, an adequate decompression should be per-
formed [37]. In case of hydrocephalus, the high risk for infection in case of long-term ventricle 
drainage can be avoided with third ventriculostomy. The compression of prepontine cistern 
usually does not cause any surgical problems; the technique can be performed in the usual way 
[37]. Regarding the routine intracerebral pressure (ICP) monitoring in case of ETV patients, it is 
not recommended, as the level of the consciousness is an indicator for the success of ETV, and 
postoperative CT scan is performed to also control the ventricle size. There are many positive 
experiences concerning ETV procedures without routine ICP monitoring [12, 37].
2.5. Hemorrhage-related obstructive hydrocephalus
An obstruction of CSF pathway can occur in case of intraventricular or intraparenchymal 
bleeding with or without intraventricular extension, cerebellar hematoma, or subarachnoid 
hemorrhage [39, 40]. In case of intraventricular or intraparenchymal bleeding related to 
obstructive hydrocephalus, ETV can be an alternative to EVD placement (Figure 7). However, 
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only a small percentage of patients with the above-mentioned pathology are optimal candi-
dates for ETV and its indication is rare [7, 39]. The gold standard for treatment of hemorrhage-
related acute hydrocephalus remains EVD placement. Acute hydrocephalus can arise either 
by intraventricular hemorrhage or by intraparenchymal hematoma with space-occupying 
effect compressing the CSF pathway. There are advantages and disadvantages of preform-
ing an ETV. The endoscopic procedure might reduce the risk of the drainage-related infec-
tions and reduce the numbers of surgical procedures, as the drainage has to be changed after 
7–10 days. In most cases, it is required to remove the blood clot. With endoscopic procedure, 
the possibility is provided; however, this procedure can be time-consuming. In case of intra-
ventricular bleeding, the endoscopic view is unclear. The visualization can be normalized 
through forced irrigation, but in case of a severe hemorrhage, the visual quality remains poor 
despite prolonged irrigation. The space-occupying intraparenchymal hemorrhage can dis-
place the ventricles depending on the localization. Furthermore, the anatomy of the prepon-
tine space and basilar artery might be distorted increasing the risk of basilar injury. In the 
acute phase, the floor of the third ventricle is thick in contrast to the subacute and chronic 
obstruction. This fact likewise causes a higher risk for basilar injury. These findings lead to 
technical challenges in the endoscopic procedure [39].
Figure 6. Obstructive hydrocephalus in case of cerebellar infarct (left above and below) preoperative CT scan—dilatation 
of temporal horn and frontal horn of lateral ventricle and third ventricle (right above and below) postoperative CT scan, 
reduced size of ventricle system.
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The clinical results are primarily influenced by the parenchymal damage. It is recommended 
to perform an ETV if the requirement of continuous ICP monitoring and liquor drainage for 
ICP reduction is excluded. In certain cases, where the CSF obstruction plays the dominant 
role and the hemorrhage does not have significant space-occupying effect, ETV might be the 
optimal option [39]. In these cases, the clinical condition can be dramatically improved. In 
all other cases, ETV should be considered if weaning the patients off the drainage is not suc-
cessful within a week. As mentioned above, the standard treatment remains EVD placement. 
Thus, in case of doubt, EVD placement should be performed, even leading to an interruption 
of ventriculostomy [39].
2.6. Infection-related hydrocephalus
Despite the indication in postinfectious hydrocephalus (meningitis, ventriculitis, and shunt 
infection) with impaired CSF absorption, or ductal, foraminal obstruction is controversial, ETV 
might be also successful in certain cases. As consequence of the infection, cisternal scarring 
might occur, leading to higher failure rate [40]. Regarding the etiology in children, the occurring 
pathogen depends on the age. Hydrocephalus following prenatal infections may be caused by 
Toxoplasmosis or Cytomegalovirus. In neonatal period, the most frequently occurring bacteria 
Figure 7. Intraventricular hemorrhage of forth ventricle with occlusive hydrocephalus. Obscured view due to the 
bleeding (above) and preoperative CT scan (left below) landmarks of third ventricle—infundibular recess, mammillary 
bodies (right below), balloon dilatation.
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are Gram-negative bacteria during the first 14 days of age and Gram-positive bacteria after the 
first 2 weeks of age. Further pathogens may be Candida species at this age of life. In postnatal 
period, hydrocephalus may be caused by bacterial (such as Haemophilus influenzae type B), 
viral, or fungal (such as Cryptococcus) infections [41]. In adults, the infection can be bacterial 
(Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, Listeria monocytogenes, 
and group B Streptococcus), viral (most frequently Enteroviruses), or fungal (Cryptococcus 
species) [42].
The tuberculous meningitis–related hydrocephalus is discussed separately, because of pecu-
liar pathological behavior. It is still a frequent disease in the developing countries [43]. As 
hematogenous dissemination from primary complex, tuberculous foci might be deposited 
in the cortex, meninges, choroidal plexus, or ventricular wall, and through rupture into the 
subarachnoid space, it leads to meningitis [44]. In acute phase, there is an acute inflammation 
in ventricles with ependymal infection and tuberculous exudate. Although the exudate can 
be washed out during ETV, ventriculostomy is more difficult due to acute inflammation and 
anatomical changes [14, 45]. In the chronic phase, the aqueduct can be obstructed by exudates, 
small tuberculomas, or infection of ependyma. In this phase, the procedure has a higher suc-
cess compared to the acute phase; however, the floor of the third ventricle is thickened, which 
could complicate the surgery [40].
2.7. Congenital malformation–related hydrocephalus
Central nervous system (CNS) anomalies might lead to congenital hydrocephalus. The most 
common cause is the congenital aqueduct stenosis as mentioned above. It can be caused by 
infection, hemorrhage before birth, or tumors [16]. In this case, endoscopic ventriculostomy is 
the treatment of choice. Ventriculostomy might be also a surgical alternative in case of Chiari 
I and II malformation with fourth ventricle outlet obstruction, myelomeningocele, syringo-
myelia, and Dandy-Walker malformation–associated hydrocephalus [13, 19, 26, 46, 47]. The 
success of ETV in these cases is diverse.
Hydrocephalus develops in considerable number in cases with neural tube defect [47, 48]. 
The incidence of hydrocephalus in patients with meningomyelocele increases after closure 
the defect [48]. Performing the endoscopic procedure may be technically difficult, due to the 
anatomical variations (enlarged interthalamic adhesion, stenosis, or atresia of foramen of 
Monro and so on) [47]. Chiari malformation can be concurred either with communicating or 
with noncommunicating hydrocephalus. Although ETV may be a good alternative for shunt 
placement in these cases, the success depends highly on the optimal selection of cases for 
endoscopic procedure [25]. In case of obstructive hydrocephalus, there is a better chance for 
success. The majority of Dandy-Walker syndrome (DWS) is associated with hydrocephalus 
[26]. In this case, the primary treatment continues to be controversial. In general, the initial 
treatment remains the shunt placement. Endoscopic excision of obstructing membrane as ini-
tial procedure is not recommended because of the associated risks for morbidity and mortality. 
ETV may be an alternative for shunt placement in patients with frequent shunt malfunction. 
In DWS concurred with aqueduct stenosis, the combination of ventricle-cyst stenting and ETV 
may be performed [26].
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2.8. Obstruction due to giant aneurysm
An obstructive hydrocephalus through giant aneurysm is rare, but it has been already reported 
in some cases [49–52]. Commonly, these cases are treated via shunt placement, although an 
aneurysm growing after shunt implantation has been already reported. The theory is that the 
decreased intracranial pressure after shunt placement reduces the tamponade effect, leading 
to aneurysm expansion and an increase in the risk for rupture [51].
In certain cases, an endoscopic ventriculostomy might be performed [49, 50]. Even though 
the anatomy is commonly changed as a consequence of the aneurysm (e.g., the third ventricle 
or aqueduct may be compressed and the anatomical structures as the floor of ventricle and 
mammillary bodies may be displaced), the landmarks can be identified and the surgery can 
be performed in the usual way [49].
2.9. Further indications for ETV
Every surgical revision after shunt implantation is considered as shunt failure. Many stud-
ies established that endoscopic third ventriculostomy in shunt failures might be an effective 
treatment option (Figure 8). The presence of shunt failure does not exercise influence on the 
failure rate of ETV. However, the success seems to be diverse in certain etiology groups [14].
It was observed that hydrocephalus patients less than 65 years of age with idiopathic normal 
pressure, where the dominant symptom was gait disturbances and only minimal cognitive 
deficits could be observed, had a good success rate [14].
Figure 8. Hydrocephalus with shunt malfunction (a and b) preoperative MRI scan, (c) scarred thick floor of the third 
ventricle, (d) perforation of adhesions in the prepontine cistern with forceps, (e) with bipolar diathermy, and (f) view on 
the cisterns through the ventriculostoma.
Hydrocephalus: Water on the Brain136
3. Surgical technique
3.1. Neuroendoscopic equipment
For endoscopic ventricular surgery, either rigid or flexible endoscope can be used. Rigid endo-
scopes have a higher image quality and allow an easier insertion and handling of instruments. 
In contrast, the flexible one allows a flexible mobility of the scope, even though producing 
a lower image quality [53]. Endoscopic equipment for ETV includes various rigid rod lens 
Hopkins optics and instruments (scissors, hooks, puncture needles, forceps for tumor biopsy 
and grasping, bright cold Xenon light source, HD video camera system, irrigation device, and 
Fogarty balloon catheter) [7].
3.2. Surgical technique
The operation is performed under general anesthesia. The patient is placed in supine position, 
the head in 3-pin fixation and tilted slightly forward. The hair is shaved and the approach is 
marked. The standard placement of the burr hole is anterior to the coronal suture and 2 cm lat-
eral to the midline. After skin disinfection and sterile draping of the operating field, the scalp is 
incised in a straight line, about 2–3 cm long. After placement of the burr hole (about 1 cm) and 
opening the dura, the operating sheath is introduced into the lateral ventricle and the trocar 
is inserted at about 5 cm depth of dura. The endoscope is fixed and the trocar is removed. The 
rigid 0° diagnostic optic is inserted for inspection and identification of the main landmarks. 
In the lateral ventricle, the fornix, the foramen of Monro, and the choroid plexus are identi-
fied (Figures 9 and 10). Under direct visual control, the endoscope is advanced through the 
foramen of Monro into the third ventricle. In the third ventricle, the main landmarks are the 
mammillary bodies and the infundibular recess. The diagnostic inspection is extended with 
Figure 9. Steps of endoscopic third ventriculostomy. (A) View of foramen of Monro, plexus choroideus, anterior septal 
vein in lateral ventricle, (B) view of mammillary bodies, infundibular recess in the third ventricle, (C) ventriculostomy 
with bipolar diathermy, (D) ventriculostoma, (E) enlarging with perforation forceps, (F) dilatation with Fogarty balloon 
catheter, (G) expanded ventriculostoma, and (H) view of basilar artery.
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30°, 45°, and/or 70° optics to view the anterior and posterior parts of the ventricles if appli-
cable. It can be useful in case of obstruction of the aqueduct or tumor. In the midline between 
the mammillary bodies and the infundibular recess, the perforation is performed. For fenes-
tration, there are several possibilities. The perforation can be performed by sharp perforation 
with semisharp probe [54], by blunt perforation with the endoscope itself, the balloon catheter 
itself [8], by coagulation with monopolar or bipolar diathermy [7, 8, 54], and by laser perfora-
tion [54, 55], waterjet dissection [55], ventriculostomy forceps [7], or ultrasonic probe [56]. It 
is recommended to use a blunt perforation to avoid vascular injury [8, 55]. In case of thick 
ventricle floor, it is recommended to use cauterization with bipolar diathermy at low energy 
[7, 8], sharp perforation with semisharp catheter [54], or waterjet dissection [55]. However, 
laser perforation and monopolar diathermy should be avoided [8]. After the perforation by 
a rigid instrument, enlarging ventriculostomy is initially performed by a perforation forceps 
and subsequently by inflation of a Fogarty balloon catheter (4–7 mm). After ventriculostomy, 
an inspection is performed with the 0° diagnostic optic to identify the dorsum sellae and the 
tip of the basilar artery to ensure free CSF flow. If a Liliequist membrane or subarachnoid 
adhesions are present, they also should be perforated (Figure 8). While withdrawing the oper-
ating sheath, an active bleeding at the foramen of Monro or at the corticotomy should be ruled 
out. After removal of instruments, a gelatin sponge is inserted in the burr hole and the galea 
is tightly closed to avoid a subgaleal CSF accumulation and leakage. The skin is sutured with 
clamp or thread. As standard, no EVD is inserted (Figure 1) [7, 9].
In case of infants up to 2 years of age, the procedure is performed in the same way; the only 
exception is that the head is fixed with bandages running over the forehead [57].
In addition, a flexible endoscope can be used for transaqueductal inspection. Following ETV, the 
work sheath should be moved posteriorly to achieve a straight approach to the Sylvian aque-
duct. If the size of diameter of the aqueduct allows it, the working optic can be withdrawn and 
Figure 10. (Left) Landmarks on the MRI scan TRUFI sequence, (L) lateral ventricle, (III.) third ventricle. Infundibular 
recess (grey arrow), mammillary body (wavy arrow), and interpeduncular and prepontine cistern (dotted arrow). 
(Right) Entry point.
Hydrocephalus: Water on the Brain138
the fiberscope inserted. After forwarding the fiberscope through the aqueduct, the patency of 
outlets of the fourth ventricle can be inspected. The fiberscope is withdrawn and a 0° diagnostic 
optic inserted to check for contusion or bleeding during the withdrawal of the work sheath [19].
4. Success rate of distinct indications
In case of a successful third ventriculostomy, the symptoms mostly improve soon after sur-
gery. Most of the patients, who suffered from deterioration of consciousness because of 
obstructive hydrocephalus, show a rapid improvement after the surgery [6]. Of course, it 
requires an adequate indication and it depends considerably on the underlying pathology 
[6, 7, 12] (Table 1).
Postoperative CT scan is routinely performed; however, the radiological findings alone do not 
count as an indicator of ETV success. It must be assessed in all cases with the clinical findings 
[6, 10, 58, 59]. After ETV, the intraventricular pressure does not decrease immediately in certain 
cases [10]. The ventricle size can increase, decrease, and remain unchanged after ventriculostomy 
[6]. In most cases, the ventricle size might correlate with the clinical outcome as early as 1 month 
after the surgery. In successful cases, a significant decrease can be seen, while it is not observ-
able or not significant in ETV failures [58, 60]. Especially, decreasing of the third ventricle size is 
Indication Success rate (%) References
Aqueduct stenosis 67–93.5 Vulcu et al. [6], Grunert et al. [9], Hellwig et al. [10], Hopf 
et al. [11], Moorthy et al. [14], Oertel et al. [63], Gangemi 
et al. [65]
Far distal obstruction 72–76 Oertel et al. [31], Mohanty et al. [26], Warf et al. [47]
Tumors 56–81 Vulcu et al. [6], Oertel et al. [7], Grunert et al. [9], Hellwig 
et al. [10], Hopf et al. [11]
Cysts 56–95 Vulcu et al. [6], Oertel et al. [7], Hopf et al. [11], Moorthy 
et al. [14], Ray et al. [27], MacArthur et al. [69]
Cerebellar infarction 86 Oertel et al. [7], Baldauf et al. [37]
Hemorrhage 43–73 Vulcu et al. [6], Oertel et al. [39], Grunert et al. [9], Siomin 
et al. [40], Roux et al. [73]
Infection 60–64 Mugamba et al. [13], Siomin et al. [40], Oertel et al. [63]
Tuberculous meningitis 60–83 Singh et al. [74], Bhagwati et al. [43]
Congenital malformations 21–80 Wu et al. [25], Mohanty et al. [26], Rei et al. [46], Warf et al. 
[47]
Giant aneurysm No adequate data
Further (e.g., 
noncommunicating HC)
65–72 Hellwig et al. [10], Moorthy et al. [14], Gangemi et al. [75]
Table 1. Success rate of ETV in distinct indication cases.
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reliable [60]. The ventricle size decreases to smaller size as measured preoperatively but remains 
still bigger than in healthy patients. It shows presumably that the absorptive mechanisms do not 
work as well as in healthy patients and the successful ventriculostomy provides a compensated 
communicating hydrocephalus [61]. The postoperative examination can be supplemented by 
MRI scan. The presence of CSF flow void, which refers to signal loss in the MRI occurring with 
CSF, may indicate the success [58]. It is important to emphasize that even without any changes 
in the ventricle size, the patient can improve clinically as a result of successful ventriculostomy.
The overall success rate of ETV is reported at 60–90% [6–12, 62] (Table 2). The initial success 
rate in the early postoperative evaluation is higher than during long-term follow-ups [6, 63]. 
Different data regarding the success rate can be explained by the different definitions of ETV 
success and with the fact that lots of studies examined mixed population regarding the age, 
the underlying pathology, the time course of the follow-up, and the strategy of patient selec-
tion [6–8]. Based on the experience and on the data, it is recommended to define the clinical 
success of third ventriculostomy as needless of re-ETV or shunt placement 3 months after the 
surgery [6, 63]. However, there is no common agreement regarding the point of time when 
a ventriculostomy is considered completely functional. In contrast, according to a Canadian 
experience, the success strictly means “no further CSF diversion procedures” [64].
As many studies have established, the success rate of the procedure depends highly on the 
underlying pathology and the age of the patients [6, 7]. Furthermore, the outcome is influ-
enced by the indications and the performing neurosurgeon [12]. An ETV Success Score (ETVSS) 
was developed by Kulkarni et al. to estimate a 6-month outcome taking age and etiology into 
account. The success score is recommended to be used while selecting the optimal candidate for 
ETV. Even though ETVSS was initially developed to predict the short-term success, the score 
likewise correlates with the long-term outcome. The score ranges between 0 and 90, where 0 
means extremely poor chance for success and 90 means very good chance for success. Regarding 
the success rate, the patients might be divided into three groups: high ETVSS-Group ≥80, mod-
erate ETVSS-Group 50–70, and Low ETVSS-Group ≤40. The optimal candidate for ETV seems to 
be the patient over 10 years of age with obstructive hydrocephalus as aqueduct stenosis or tectal 
tumor and without infection, cerebral hemorrhage, or previous shunting in case history [5].
4.1. Aqueduct stenosis
Endoscopic ventriculostomy has the most favorable outcome in case of benign aqueduct ste-
nosis (67–93.5%) [6, 7, 9–11, 14, 63, 65]. This fact supports the assumption that the therapy of 
Age group Overall success  
rate (%)
References
Adults 60–90 Vulcu et al. [6], Schroeder et al. [8], Grunert et al. [9], 
Hellwig et al. [10], Hopf et al. [11], Sacko et al. [12], 
Siomin et al. [62]
Children > 2 years 66–71 Vulcu et al. [6], Grunert et al. [9], Baldauf et al. [80], Oertel 
et al. [81], Beems and Grothenius [82], Etus et al. [83]Children < 2 years 22–67
Table 2. Overall success rate considering the age groups.
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choice is ETV. Nevertheless, the success rate in each case depends on the etiology, age, clini-
cal findings, and radiological characteristics [13]. The presence of aqueduct obstruction with 
free prepontine cistern is associated with significantly better outcome of ETV [66]. Regarding 
the etiology, the acquired stenosis has a better success result than the congenital form [67]. 
The clinical manifestation of the congenital form appears earlier than the acquired one, which 
contributes to the lower success rate. In infants, the success of the procedure seems to depend 
on the age as well as on the etiology. Under the age of 1 year, ETV also has higher success rate 
in case of aqueduct stenosis than in case of other etiology, although significantly less than in 
older children [9, 68]. Regarding age, the success seems to be related not only to the age at 
the time of the surgery but also to the age at onset of the pathological changes [13]. The dif-
ferent range of success rate derives from the fact that the studies examine mixed population 
regarding age and pathology [16] .
4.2. Far distal obstruction
Obstruction distal to the fourth ventricle is a rare cause of HC, but in any case, ETV might be 
a successful treatment with 72–76% of postoperative success [19, 26, 47].
4.3. Tumor and cystic lesions
The intraventricular, pineal region, infratentorial tumor- and cyst-related obstructive hydro-
cephalus has a high success rate after third ventriculostomy (56–81%, in cysts over 90%) [6, 7, 
9–11, 63]. The best candidates seem to be patients with aqueduct obstruction in case of tectal 
tumors, pineal region tumors or cysts, and third ventricle tumors [11, 15, 27]. Simultaneously 
performing tumor mass resection or biopsy is also possible in certain cases. The success of 
ventriculostomy with simultaneous tumor removal or biopsy is reported [7, 69]. Another 
option is to perform ventriculostomy before or after the tumor surgery. There are diverg-
ing opinions on the timing [14]. The preceding ventriculostomy may reduce the chance 
for postoperative hydrocephalus in case of posterior fossa tumors [70, 71]. In case of cysts, 
a cyst resection or a fenestration between the cyst and the ventricle simultaneously may 
be performed to ETV. The success rate in these cases reaches 56–95% [6, 7, 11, 14, 27, 69]. 
After tumor removal, the cause of obstruction can be eliminated restoring the normal CSF 
flow. Therefore, performing ETV routinely is not necessary [32]. In case of posterior fossa 
tumors, higher success is established if hydrocephalus persists after tumor resection [72]. 
On the other hand, there are studies where the rate in case of tumors is significantly lower 
(56%) [6]. The different data can be explained by the fact that many studies do not differen-
tiate between benign space-occupying lesions and progressive tumors; however, there is a 
significant difference between the two groups regarding the outcome [11]. The success of 
ETV depends on the localization and the growth pattern of the tumor. A progressive tumor 
is more likely to close the ventriculostoma earlier than a benign lesion or cysts. The same 
applies to a lesion in the third ventricle compared to an infratentorial tumor, which has no 
direct connection to the new CSF flow diversion. Likewise, the duration of the symptoms 
seems to be an influencing factor [7]. Regarding the surgical technique, it can be performed 
in a relatively uncomplicated way, but the obscuration of the ventricle anatomy by the tumor 
might cause difficulties [10, 14].
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4.4. Cerebellar infarction
A cerebellar ischemic stroke might lead to obstruction of CSF pathway through the paren-
chymal edema. The occlusion can be treated with EVD or ETV depending on the endoscopic 
experiences of the surgeon. The ideal management is still controversial. An endoscopic ven-
triculostomy might be recommended if no brainstem compression exists [37]. The overall suc-
cess of ETV in this case is about 86% [7]. Under certain circumstances, this etiology seems to be 
ideal for ETV, probably because of the acute onset and the pure obstructive origin [7]. The main 
indicator for successful ETV seems to be the level of consciousness. In case of no improvement 
of deteriorated consciousness despite ventriculostomy or in case of brainstem compression, a 
suboccipital decompression is required [37].
4.5. Hemorrhage-related obstructive hydrocephalus
The optimal management in case of hemorrhage-related obstructive hydrocephalus is still 
controversial. The overall success rate is 43–73% [6, 9, 39, 40, 63, 73], which is significantly 
lower than in other etiologies mentioned above. In this case, a difference was also established 
regarding the outcome in various age groups. The younger population has a lower success 
rate than the adult group. Moreover, in combination with infection, the rate is about 23% [40]. 
Evaluating the success of ETV remains difficult in any case, because of the adverse prognoses 
and clinical status in case of extensive intraparenchymal or intraventricular hemorrhage [39].
4.6. Infection-related hydrocephalus
The overall success rate amounts for about 60–64% in case of obstructive hydrocephalus 
caused by infection [13, 40, 63], even though adults benefit more from the procedure than 
children [13, 40]. The success of ventriculostomy depends on whether a prepontine scarring 
exits. In many case, ETV cannot be performed, because of intraventricular, ependymal scar-
ring and anatomical distortion. In contrast, an obstruction, especially of the Sylvian aqueduct 
in postinfectious hydrocephalus, promises a better outcome [45]. As mentioned above, infec-
tion combined with hemorrhage has a lower success rate [40].
In tuberculous meningitis, the exudate is deposited in basal cisterns leading to an obstruction 
at the level of Sylvian aqueduct, at the outlet of fourth ventricle, or in the subarachnoid space 
[14]. ETV success amounts for about 60–83% in this case [43, 74]. The difference of the success 
depends highly on the thickness of the ventricle floor and the presence of the exudate. In acute 
phase, the tuberculous exudates in ventricle system and subarachnoid space and the inflam-
mation of ependyma may impede the surgery and lead to lower success rate [14].
4.7. Congenital malformation–related hydrocephalus
Although opinions vary widely about the role of ventriculostomy in congenital CNS malforma-
tion–related hydrocephalus, it may be a successful option in certain cases [13, 26, 46, 47]. The 
overall success rate in case of brain malformation–related hydrocephalus amounts to 21–80% [25, 
26, 46, 47]. These various rates may be explained by the fact that most surgeries are performed 
in infancy, which considerably influences the outcome. Moreover, obstructive hydrocephalus 
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 overall has a higher ETV success rate compared with noncommunicating hydrocephalus. In 
patients with meningomyelocele, the success may be higher if ETV is combined with choroid 
plexus cauterization [47]. In case of Chiari malformation type I and syringomyelia-related hydro-
cephalus, a shunt independency with a high rate of causing a high ETV success may achieved 
[14]. The reduction of the caliber, even a resolution of the syrinx, was observed [13, 14].
4.8. Obstruction due to giant aneurysm
Successful endoscopic ventriculostomy was reported in some giant aneurysm–related obstruc-
tion [49, 50]. The most feared complications are related to vascular injury leading to infarction, 
hemorrhage, or pseudoaneurysm development [49]. Although, as mentioned above, some 
successful ETV was reported, where the procedure seemed to be a good option for treatment 
of obstructive hydrocephalus, the experiences and reports in these cases are wanting.
4.9. Success in cases of further indications for ETV
In case of normal- and low-pressure hydrocephalus and malabsorptive hydrocephalus, the suc-
cess rate amounts about 65–72% [10, 14, 75]. In patients less than 65 years of age and with com-
municating hydrocephalus, with only minimal cognitive deficits, where the dominant symptom 
is gait disturbance, the success rate is comparable with the rate after shunt placement [14].
The success in case of shunt malfunction or infection was observed in similar percentage of 
67–80% [14, 76]. An exact indication for ETV in communicating hydrocephalus and shunt mal-
function has not been defined yet, but as it can be seen, it may be an alternative in certain cases.
As mentioned earlier, patients with shunt malfunction might be treated successfully with ETV 
in certain cases as well. It is clear that a patient with aqueduct stenosis benefits more from ven-
triculostomy following shunt malfunction than patients with other etiologies. Consequently, 
ventriculostomy can be recommended in case of shunt malfunction if an obstruction exits in 
the CSF pathway. In contrast, patients without obstruction should be treated with shunt revi-
sion [77]. Following ventriculostomy, it is recommended to remove the shunt system to avoid 
the intermittent CSF diversion through the shunt [14].
4.10. Children
The debate is still open, whether the etiology or the age is the determining factor of ETV success 
in children. The overall success rate reaches about 66–71% in children [6, 7, 9]. In children under 
2 years of age, having the chance for a success is significantly lower (22–67%), and infants under 
6 months have the worst chance for restoration of the CSF circulation [6, 7, 9, 78–81]. While 
trying to predict the success using ETVSS, the age plays an important role [5]. The outcome 
has been examined in several studies regarding the underlying pathology in children, and the 
difference was also conspicuous between the various etiology groups [9, 78, 80, 81]. The final 
results correlate with data in adults. Patients with aqueduct stenosis overall have very favor-
able outcome [9, 78, 81]. Despite all these data, there are studies where no difference regarding 
the age [4] or etiology [82] was found. Nevertheless, based on the experiences and studies, the 
outcome seems to depend both on the underlying pathology and on the age [78, 83, 84].
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5. Failure rate and complications
5.1. Complications and their prevention
Endoscopic ventriculostomy is considered less noninvasive and safe. The complications are 
rare and mostly related to the surgical procedure [85]. The average morbidity is 8.5% and mor-
tality <1% [8, 11, 31, 85]. Permanent deficits are rare with an average value up to 2.38% [85], 
while the transient morbidity ranged up to 7.8% [8, 85].
The most feared complication is the vessel injury. Minor hemorrhage can be caused by 
small vessel injuries, for example in the cortex, brain parenchyma, choroid plexus, or mar-
gin of ventriculostoma during inflation of the Fogarty catheter. Minor hemorrhage can be 
managed with irrigation to achieve a tamponade effect [8, 55, 85]. In case of insufficient 
irrigation, coagulation with bipolar diathermy should be performed [8]. Major hemorrhage 
caused by injury of basilar artery and basilar perforating vessels, thalamostriate vein, or 
anterior septal vein injury can lead to uncontrollable hemorrhage and life-tethering situa-
tion with fatal outcome. Minor hemorrhage occurs in up to 16.5%, whereas major ones occur 
only in 0.49% [85]. These may occur for example due to false placement of instruments [7]. 
Brain nerve injury may occur in the same way [7, 85]. In many diseases such as developmen-
tal anomalies and tumors, the anatomy is distorted making the surgical technique difficult 
[85]. By using a rigid endoscope and correct position of fenestration, these complications 
can be avoided. Thorough inspection of the anatomical relationships on the preoperative 
MRI scan is essential.
Further complications may be epidural or subdural hematoma [8, 86–88], fornix contusion 
[8, 31], traumatic damage of thalamus and hypothalamus with endocrine and electrolyte dis-
turbances [31, 85], hemodynamic alterations [6, 85], cerebral herniation syndrome in case of 
obstructed outflow channel or excessive irrigation [8, 85], CSF leakage [8, 85], abandoned 
procedure, or ETV failure (see below) [6, 12, 62, 63, 89]. The incidence of abandoned proce-
dure ranges from 0 to 26% [8]. The most frequent causes are hemorrhage, complex anatomical 
circumstances, or inability to fenestrate the ventricle floor [8]. Postoperative infection may 
lead to meningitis, ventriculitis, brain abscess, or sepsis. Further nonspecific complication as 
thrombophlebitis, pneumonia, or wound infection may occur.
Summarizing, to prevent the complications, individual anatomical variations should be 
evaluated in the preoperative imaging. The relationship between the third ventricle floor 
and basilar artery should be thoroughly considered. The adequate technique with rigid 
instrument should be used and one has to consider the correct energy intensity and sources. 
As mentioned above, it is recommended to use low energy (maximum 10 W) and to avoid 
laser and monopolar diathermy. The correct placement of fenestration is essential; ideally, 
it is placed halfway between the mammillary bodies and infundibular recess in the midline. 
However, individual variations should be considered. After the perforation, the interpedun-
cular and prepontine cistern should be inspected and adhesions or the Liliequist membrane 
should be perforated.
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5.2. Failure rate and re-ETV
Re-occlusion of the ventriculostoma is rare. Kulkarni et al. have reported that ETV has an 
initial higher failure rate in contrast to shunt placement, although it gets lower over time [5]. 
Most failures (58–97%) occur within the first 3 months [6, 7, 12, 62]. Within the first year, ETV 
failure reaches 16–20% [6, 62]. However, it might also develop after years; therefore, a long-
term follow-up after the surgical procedure is required [12, 62, 89]. It remains controversial, 
whether re-ETV or shunt placement is the optimal choice of treatment for ETV failure. The 
decision depends on the age, etiology of hydrocephalus, imaging finding, and the duration 
between ventriculostomy and failure [63, 90]. In certain cases, repetition of ventriculostomy 
as the first choice is recommended, as a similar long-term success of 51–89% is expected 
[7, 16, 62, 63, 89, 91–94]. Some authors differentiate early failure from late failure, but the 
distinction between the two definitions is various (7 days—6 months) [4, 63, 89, 91, 93]. 
Multifactorial etiology including malabsorptive component, complications including hemor-
rhage and infection or technical failure as inadequate size of stoma with insufficient CSF flow 
through the stoma, and unperforated Liliequist membrane could be responsible for early 
failure [4, 63, 89, 93, 94]. The ideal size of stoma is not defined, and it seems to depend highly 
on the anatomy, while in case of a size between 4 and 7 mm, failures were also reported [89]. 
To avoid an intermitting CSF diversion through the shunt, ligature or removal of the shunt 
system is recommended, as mentioned above. Late failure could be caused by secondary 
closure as tumor progression, gliosis, and developing of membranes and adhesions in the 
subarachnoid space [4, 6, 11, 89, 91]. In children, the absorption of CSF at the Pacchionian 
granulations is immature [95], which may play a role in ETV failure. Further cause for failure 
might be the multifactorial etiology in certain cases [4]. The success of re-ETV is found higher 
in case of late-repeat-ETV than in early ones [63, 91, 96], although there are some contro-
versial results [62]. As indicated above, the failure rate decreases during the follow-up [63]. 
Regarding the age, the results are controversial, but in most studies, higher failure rates are 
reported when less than 6–24 months of age [4, 63, 89]. Regarding the pathology, the failure 
rate amounts 10–20% in aqueduct stenosis, while in other indication cases, it amounts up to 
50% [14]. If no obstructive cause for failure is seen on the MRI scan, a shunt placement is con-
sidered [63] taking a multifactorial etiology including malabsorptive mechanism as cause of 
failure. Re-ETV is also not recommended in case of tumor progression–related closure [89]. 
There are no exact criteria defined for repetition of ETV; an individual evaluation in all cases 
is expressly recommended.
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